"Le Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM) est le plus grand centre de recherche en sciences biomédicales et soins de santé de l’Université de Montréal, et parmi les plus imposants au Canada."

During the past decade, CHUM - Hôtel Dieu conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 33 clinical trials were completed, i.e. on average, 194.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 16 clinical trials were completed. i.e. 1600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHUM - Hôtel Dieu" #1 sponsor was "Gilead Sciences" with 7 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "Montreal Heart Institute" with 4 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Advanz Pharma" with 4 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHUM - Hôtel Dieu" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 85 trials.

According to Clinical.Site data, the most researched conditions in "CHUM - Hôtel Dieu" are "Breast Cancer" (12 trials), "Atrial Fibrillation" (5 trials), "Heart Failure" (4 trials), "Huntington Disease" (4 trials) and "HIV Infections" (3 trials). Many other conditions were trialed in "CHUM - Hôtel Dieu" in a lesser frequency.

Most popular intervention types in "CHUM - Hôtel Dieu" are "Drug" (56 trials), "Other" (21 trials), "Procedure" (10 trials), "Biological" (8 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Laboratory Biomarker Analysis" (7 trials), "placebo" (6 trials), "Quality-of-Life Assessment" (4 trials) and "cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "CHUM - Hôtel Dieu" are 68 trials for "All" genders, 20 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CHUM - Hôtel Dieu". undefined are not yet recruiting, 3 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in CHUM - Hôtel Dieu, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in CHUM - Hôtel Dieu, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".